Miruvor
ME/CFS RelapsedBenefit faded or relapsed

Gcmaf-reactions and side effects

Condition
ME/CFS
At worst
Not stated
Ill for
Not stated
Published
Undated

Summary

Monthly injections of GcMAF at 1/5 dose from a new "blue-top vial" batch produced an unusual immediate headache, and within the following week she "relapsed terribly" with daily severe depression, near-daily adrenal crashes and head inflammation. She suspected the new batch was more potent than her previous supply. This is a clear worsening directly following the injection rather than any benefit.

Read it in their words

forums.phoenixrising.me

What they credit

Credits Biologics & antibodies, Surgery & structural, GcMAF, Goleic and Bravo yoghurt.

Symptoms mentioned

Symptoms: Anxiety & low mood, Headaches & migraine.

Similar stories

  • I was cured with GCMAF

    Full recovery ME/CFS Very severeIll 9 years forums.phoenixrising.me Dec 2017

    After 9 years ill, severely bedbound and intolerant of touch, light, sound and movement for over 3 years, she injected Goleic (oleic-acid-conjugated GcMAF) every 4 days for just over a year, having tried many other alternative treatments without success…

  • I was cured with GCMAF

    No benefit ME/CFS forums.phoenixrising.me Dec 2017

    Tried Natural Regenesis colostrum-based GcMAF sublingually (held under the tongue about 10 minutes). Experienced increased gut inflammation, similar to a reaction he'd had to GcMAF cream previously, and concluded plainly "GcMAF is not for me" - a…

  • Colostrum Maf

    Partial ME/CFS forums.phoenixrising.me Dec 2017

    Took bovine colostrum powder mixed into a cocoa drink and reported "feeling better" within just 3 days. She flags the result herself as confounded, since she "also started microdosing psilocybin once every 4 days at the same approximate time, so it might be…

  • Colostrum Maf

    No benefit ME/CFS forums.phoenixrising.me Dec 2017

    Used Dr Enlander's injectable GcMAF and developed nerve pain in his feet, leading him to discontinue. No benefit is reported before stopping; presented purely as an adverse-effect-driven discontinuation.